Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia

Molecular Human Reproduction

Volumn 20, Issue 10, 2014, Pages 1026-1040

  Rahat, Beenish ^a   Hamid, Abid ^b   Najar, Rauf Ahmad ^b   Bagga, Rashmi ^a   Kaur, Jyotdeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

DNA methylation; Gestational trophoblastic diseases; Histone modifications; Placenta; Pre eclampsia

Indexed keywords

MYC PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; HISTONE; MESSENGER RNA; MYC PROTEIN, HUMAN; TELOMERASE;

ADULT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTROPHOBLAST; DNA METHYLATION; EPIGENETICS; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RESOLUTION MELTING ANALYSIS; HISTONE MODIFICATION; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PROMOTER REGION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; BIOSYNTHESIS; CELL CULTURE; CPG ISLAND; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; PREGNANCY COMPLICATION; REPRODUCTION; TROPHOBLAST; UTERUS CANCER;

ADULT; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HISTONES; HUMANS; HYDATIDIFORM MOLE; PLACENTA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TELOMERASE; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 84917743634     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gau053     Document Type: Article

References (75)

1. Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill PW. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27:415-418.
2. Allsopp R, Shimoda J, Easa D,Ward K. Long telomeres in the mature human placenta. Placenta 2007;28:324-327.
3. Alsat E, Guibourdenche J, Couturier A, Evain-Brion D. Physiological role of human placental growth hormone. Mol Cell Endocrinol 1998; 140:121-127.
4. Atkinson SP, Hoare SF, Glasspool RM, Keith WN. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 2005;65:7585-7590.
5. Bamberger AM, Bamberger CM, Aupers S, Milde-Langosch K, Loning T, Makrigiannakis A. Expression pattern of the activating protein-1 family of transcription factors in the human placenta. Mol Hum Reprod 2004; 10:223-228.
6. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007; 128:669-681.
7. Bischof P, Meisser A, Campana A. Biochemistry and molecular biology of trophoblast invasion. Ann N Y Acad Sci 2001;943:157-162.
8. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of PE. J Clin Endocrinol Metab 2007;92:3517-3522.
9. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of PE. Obstet Gynecol Annu 1972;1:177-191.
10. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999;103:1641-1650.
11. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-2218.
12. Chen RJ, Chu CT, Huang SC, Chow SN, Hsieh CY. Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies. Hum Reprod 2002;17:463-468.
13. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, Oudejans CB, Ding C, Lo YM. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005;102: 14753-14758.
14. Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, Lo YM. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-1613.
15. ChiuRW, Chim SS,Wong IH,Wong CS, Lee WS, To KF, Tong JH, Yuen RK, Shum AS, Chan JK et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007;170:941-950.
16. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-138.
17. Cross JC,Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science 1994;266:1508-1518.
18. D'Alessio AC, Szyf M. Epigenetic tete-a-tete: the bilateral relationship between chromatin modifications and DNA methylation. Biochem Cell Biol 2006;84:463-476.
19. Dokras A, Coffin J, Field L, Frakes A, Lee H, Madan A, Nelson T, Ryu GY, Yoon JG. Epigenetic regulation of maspin expression in the human placenta. Mol Hum Reprod 2006;12:611-617.
20. EstellerM. Cancer epigenomics:DNAmethylomes and histone-modification maps. Nat Rev Genet 2007;8:286-298.
21. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998; 4:909-914.
22. Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 2007;13:121-141.
23. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J, Damsky CH. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol 1989;109:891-902.
24. Foltankova V, Legartova S, Kozubek S, Bartova E. Tumor-specific histone signature and DNA methylation in multiple myeloma and leukemia cells. Neoplasma 2012;59:450-462.
25. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005;37:391-400.
26. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I, Berkowitz RS. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 1998; 43:101-110.
27. Gearhart J, Pashos EE, Prasad MK. Pluripotency redux-advances in stem-cell research. N Engl J Med 2007;357:1469-1472.
28. Geifman-Holtzman O, Xiong Y, Holtzman EJ, Hoffman B, Gaughan J, Liebermann DA. Increased placental telomerase mRNA in hypertensive disorders of pregnancy. Hypertens Pregnancy 2010;29:434-445.
29. Gomez DE, Armando RG, Farina HG, Menna PL, Cerrudo CS, Ghiringhelli PD, Alonso DF. Telomere structure and telomerase in health and disease (review). Int J Oncol 2012;41:1561-1569.
30. Goustin AS, Betsholtz C, Pfeifer-Ohlsson S, Persson H, Rydnert J, Bywater M, Holmgren G, Heldin CH, Westermark B, Ohlsson R. Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Cell 1985;41:301-312.
31. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall' Olio V, Zardo G, Nervi C, Bernard L, Amati B. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 2006;8:764-770.
32. Hemberger M. Epigenetic landscape required for placental development. Cell Mol Life Sci 2007;64:2422-2436.
33. Hoffner L, Surti U. The genetics of gestational trophoblastic disease: a rare complication of pregnancy. Cancer Genet 2012;205:63-77.
34. Horikawa I, Cable PL, Afshari C, Barrett JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999;59:826-830.
35. Janneau JL, Maldonado-Estrada J, Tachdjian G, Miran I, Motte N, Saulnier P, Sabourin JC, Cote JF, Simon B, Frydman R et al. Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 2002;87:5336-5339.
36. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
37. Kimura AP, Liebhaber SA, Cooke NE. Epigenetic modifications at the human growth hormone locus predict distinct roles for histone acetylation and methylationinplacentalgene activation.MolEndocrinol2004;18:1018-1032.
38. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31:89-97.
39. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008;40:741-750.
40. Lachner M, Jenuwein T. The many faces of histone lysine methylation. Curr Opin Cell Biol 2002;14:286-298.
41. Lawler SD, Pickthall VJ, Fisher RA, Povey S, EvansMW, Szulman AE. Genetic studies of complete and partial hydatidiform moles. Lancet 1979;2:580.
42. Li Q, Costa M. c-Myc mediates a hypoxia-induced decrease in acetylated histone H4. Biochimie 2009;91:1307-1310.
43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
44. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sexmismatched bone marrow transplantation. Clin Chem 2002;48:421-427.
45. Martinato F, Cesaroni M, Amati B, Guccione E. Analysis of Myc-induced histone modifications on target chromatin. PLoS One 2008;3:e3650.
46. Migheli F, Stoccoro A, Coppede F, Wan Omar WA, Failli A, Consolini R, Seccia M, Spisni R, Miccoli P, Mathers JC et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One 2013;8:e52501.
47. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y,Wilson KS, White MA, Wright WE, Shay JW. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999;21: 115-118.
48. Nakamura TM, Cech TR. Reversing time: origin of telomerase. Cell 1998; 92:587-590.
49. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 2004;24:6076-6083.
50. Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, Morley R, Down T, Beck S, Craig JM et al. Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 2008;14:547-554.
51. Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan V, Down T, Beck S, Fournier T, Evain-Brion D, Dimitriadis E et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009;284:14838-14848.
52. Ohlsson R. Growth factors, protooncogenes and human placental development. Cell Differ Dev 1989;28:1-15.
53. Osterlund C,Wramsby H, Poussete A. Temporal expression ofPDGF-Aand its receptor in human pre-implantation embryos. Mol Hum Reprod 1996; 2:507-512.
54. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004;23:4061-4071.
55. Pfeifer-Ohlsson S, Goustin AS, Rydnert J, Wahlstrom T, Bjersing L, Stehelin D, Ohlsson R. Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation. Cell 1984;38:585-596.
56. Pijnenborg R, Bland JM, Robertson WB, Dixon G, Brosens I. The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. Placenta 1981;2:303-316.
57. Rahnama F, Shafiei F, Gluckman PD, Mitchell MD, Lobie PE. Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology 2006;147:5275-5283.
58. Rama S, Suresh Y, Rao AJ. Regulation of telomerase during human trophoblast differentiation: a role for TGF b1. Mol Cell Endocrinol 2001; 182:233-248.
59. Redman CW. Cytotrophoblasts: masters of disguise. Nat Med 1997; 3:610-611.
60. Roncalli M, Bulfamante G, Viale G, Springall DR, Alfano R, Comi A, Maggioni M, Polak JM, Coggi G. C-myc and tumour suppressor gene product expression in developing and term human trophoblast. Placenta 1994;15:399-409.
61. Serman L, Vlahovic M, Sijan M, Bulic-Jakus F, Serman A, Sincic N, Matijevic R, Juric-Lekic G, Katusic A. The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta 2007;28:803-811.
62. Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY et al. Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 2005;113:264-268.
63. Soundararajan R, Rao AJ. Trophoblast 'pseudo-tumorigenesis': significance and contributory factors. Reprod Biol Endocrinol 2004;2:15.
64. Strickland S, Richards WG. Invasion of the trophoblasts. Cell 1992; 71:355-357.
65. Suman P, Gupta SK. Comparative analysis of the invasion-associated genes expression pattern in first trimester trophoblastic (HTR-8/SVneo) and JEG-3 choriocarcinoma cells. Placenta 2012;33:874-877.
66. Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007;445:214-218.
67. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011;7:467-474.
68. Wang J, Mager J, Schnedier E, Magnuson T. The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. Mamm Genome 2002;13:493-503.
69. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35:e41.
70. Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat Protoc 2008;3:1903-1908.
71. Wong NC, Novakovic B, Weinrich B, Dewi C, Andronikos R, Sibson M, Macrae F, Morley R, Pertile MD, Craig JM et al. Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. Cancer Lett 2008; 268:56-62.
72. Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J 2003; 17:767-769.
73. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007;11:407-420.
74. Zhang B, Chen J, Cheng AS, Ko BC. Depletion of sirtuin 1 (SIRT1) leads to epigenetic modifications of telomerase (TERT) gene in hepatocellular carcinoma cells. PLoS One 2014;9:e84931.
75. Zhao F, Wang J, Liu R, Yang J, Cui K, Wu Y, Guo J, Mu Y, Wang X. Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma. Prenat Diagn 2010;30:778-782.